Walleye Capital
VRDN icon

Walleye Capital’s Viridian Therapeutics VRDN Stock Holding History

Walleye Capital’s Portfolio VRDN Stock Details VRDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.06M Sell
54,398
-6,444
-11% -$191K 0.01% 2023
2025
Q4 		$1.89M Buy
60,842
+10,199
+20% +$280K 0.01% 1919
2025
Q3 		$1.09M Sell
50,643
-13,913
-22% -$251K 0.01% 2019
2025
Q2 		$902K Sell
64,556
-39,461
-38% -$536K 0.01% 2136
2025
Q1 		$1.4M Sell
104,017
-377,622
-78% -$6.43M 0.02% 1709
2024
Q4 		$9.23M Sell
481,639
-78,368
-14% -$1.7M 0.09% 679
2024
Q3 		$12.7M Buy
560,007
+129,411
+30% +$2.12M 0.14% 563
2024
Q2 		$5.6M Buy
430,596
+424,960
+7,540% +$5.88M 0.06% 1206
2024
Q1 		$98.7K Sell
5,636
-235,775
-98% -$4.57M ﹤0.01% 4401
2023
Q4 		$5.26M Buy
241,411
+227,881
+1,684% +$3.6M 0.07% 1078
2023
Q3 		$208K Sell
13,530
-73,590
-84% -$1.4M ﹤0.01% 3528
2023
Q2 		$2.07M Sell
87,120
-29,537
-25% -$758K 0.04% 1298
2023
Q1 		$2.97M Buy
116,657
+70,515
+153% +$2.26M 0.06% 505
2022
Q4 		$1.35M Sell
46,142
-143,387
-76% -$3.3M 0.03% 805
2022
Q3 		$3.89M Buy
189,529
+11,078
+6% +$199K 0.09% 288
2022
Q2 		$2.06M Buy
178,451
+16,170
+10% +$217K 0.06% 358
2022
Q1 		$3M Buy
162,281
+52,106
+47% +$1M 0.09% 257
2021
Q4 		$2.18M Buy
110,175
+87,674
+390% +$1.63M 0.07% 311
2021
Q3 		$370 Buy
+22,501
New +$330K 0.01% 925

Other funds holding VRDN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return